跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 392,524 条关于
“Hong Kong Exchanges and Clearing”
全部
392,524
临床试验
344,826
药物
4,482
机构
2,436
资讯
40,780
3个月前
Hong Kong Chamber Urges Removal of 'Novelty Test' to Ease Listing Rules for Biotech and Innovative Companies
5个月前
Hong Kong Launches Primary Evaluation System for Independent Drug Approval
去年
Hong Kong Launches First Clinical Trial Institute, Prioritizes HIV Vaccine Research
3个月前
ESMO TAT Asia 2026 Highlights AI-Driven Drug Development, Theranostics, and Gastric Cancer Advances in Hong Kong
去年
Kadimastem Secures Hong Kong Patent for IsletRx Stem Cell Diabetes Therapy
去年
Hengrui Pharmaceuticals Aims to Raise $1.27 Billion in Hong Kong IPO
去年
Eli Lilly's Tirzepatide (Mounjaro) Approved in Hong Kong for Weight Management and Type 2 Diabetes
去年
Hong Kong Achieves First Myeloma CAR-T Treatment Using Mainland-Manufactured Therapy
去年
Avalon GloboCare Secures Hong Kong Patent for Bispecific CAR-T and CAR-NK Cell Technology
去年
Hong Kong Streamlines Drug Registration Process with New Consultation Services
第 1 页，共 4078 页
上一页
下一页
